Explain this page
Arphra AIPlain-English read on Global X - Silver Miners ETF’s valuation06-10today
- Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer18h
- SIL: The Real Silver Nugget Is Here8d
- Silver leads metals higher as traders defend key support - Kitco PM Report12d
- CEO WARNS: Silver demand is EXPLODING and the world CANNOT keep up13d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →SIL
83.73-10.28%H 118.85L 74.09MA50 91.14MA200 —Avg vol 2.6M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.47% | -8.69% | -10.87% | -5.08% | -11.20% | -5.97% | +63.30% | +207.00% | +80.40% | +103.50% | +77.59% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$78.85
Bid
$78.56
1 sh
Ask
$82.21
1 sh
Spread
$3.650
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Industrials+1.00%
- Basic Materials+0.65%
- Energy+0.59%
- Financial Services+0.23%
- Healthcare-0.18%
- Communication Services-0.18%
- Consumer Defensive-0.30%
- Consumer Cyclical-0.85%
- Real Estate-0.99%
- Utilities-1.03%
Top industries (issuer's industry highlighted)
- Software - Services+9.60%
- Broadcasting+8.34%
- Medical - Equipment & Services+5.08%
- Computer Hardware+4.56%
- Financial - Mortgages+4.08%
- Staffing & Employment Services-3.62%
- Internet Content & Information+3.58%
- Coal-3.56%
- Oil & Gas Energy-3.54%
- Biotechnology+3.28%
- Electrical Equipment & Parts+3.27%
- Luxury Goods-2.86%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancerglobenewswire.com·Jun 23, 2026
- SIL: The Real Silver Nugget Is Hereseekingalpha.com·Jun 15, 2026
- Silver leads metals higher as traders defend key support - Kitco PM Reportkitco.com·Jun 11, 2026
- CEO WARNS: Silver demand is EXPLODING and the world CANNOT keep upyoutube.com·Jun 10, 2026
- Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Centerglobenewswire.com·May 13, 2026
- Silver's push above $80 reflects structural shift in the global economykitco.com·May 12, 2026
- Shortages, Solid-State, and Swing Highs: The 3-Step Checklist For Silver's Next Vertical Movebenzinga.com·May 12, 2026
Peers
No peer list available for SIL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|